On this page
Quick answer
Medicines are part of comprehensive care. Sufficient, varied nutrition, adapted activity and healthcare follow-up remain important. Weight regain after withdrawal is possible and should be anticipated with the healthcare team.
Educational information for adults. This is not a prescription or an individual medical assessment. Longevity Online is a wellbeing plan: it does not include medicines or obesity treatment. GLP‑1 use requires a medical indication, prescription and healthcare follow-up.
Medical terms, explained
Hover, use keyboard focus or tap an underlined word to see its meaning.
Read all definitions
- GLP-1
- Glucagon-like peptide-1: a gut hormone involved in insulin release after eating and appetite regulation. Source
- GIP
- Glucose-dependent insulinotropic polypeptide: a gut hormone that helps release insulin in response to food. Source
- BMI
- Body mass index: weight in kilograms divided by height in metres squared. An indicative measure, not a measure of body composition. Source
- Waist/height
- Waist circumference divided by height in the same units. Helps assess central adiposity alongside BMI; it is not a diagnosis. Source
Why does nutrition still matter?
Reduced hunger does not guarantee adequate nutrition. General guidance is to maintain variety, hydration and sufficient intake. If digestive symptoms make eating or drinking difficult, discuss them with the healthcare team.
There is no universal therapeutic diet. Related conditions, nutritional needs and symptoms require individualisation; this guide does not set calories, supplements or protein amounts.
What role do movement and strength play?
Physical activity is part of obesity care and should fit abilities, limitations and preferences. Goals also include function and independence, not only a number on the scales.
Sleep habits and behavioural support form part of care. A digital wellbeing plan can help organise routines, but does not replace symptom assessment, medication supervision or clinical nutrition care.
What happens when treatment is withdrawn?
In the STEP 1 extension, participants regained on average approximately two thirds of their previous weight loss in the year after both semaglutide and the trial's lifestyle intervention were withdrawn. Some cardiometabolic improvements moved back towards baseline.
The extension involved a trial subgroup and was exploratory. It cannot attribute all changes solely to stopping the medicine or establish that everyone will regain the same amount. It does not define a withdrawal schedule.
Continuity, cost, tolerance and maintenance should be discussed with the prescriber. Do not change treatment based on this page.
BMI and waist-to-height ratio
An indicative tool for adults aged at least 18 who are not pregnant. Enter height and weight; waist measurement is optional. All length measurements must be in centimetres (cm).
Calculated on this device. These measurements are not saved or sent anywhere.
These results are neither a diagnosis nor a probability of disease. No number alone indicates treatment with GLP-1 or any other medicine; decisions require clinical assessment.
How to read these numbers
This tool excludes people under 18 and pregnant people. BMI does not distinguish fat from muscle: high muscle mass can affect its interpretation. For adults over 65, function, nutritional status and other circumstances must be considered. Clinical context and ethnic background also matter: no universal BMI classification is applied here to everyone.
NICE NG246 uses waist-to-height ratio alongside BMI in adults with BMI <35. Its bands are a central adiposity reference, not an assessment of overall health.
Technical validation limits: height 100–250 cm, weight 20–400 kg and waist 30–250 cm. These are not clinical cut-offs and do not define what is healthy; consult a professional if your measurements fall outside them.
Source: NICE NG246 · recommendations 1.9.5, 1.9.8, 1.9.14 and 1.9.15 (Opens in a new tab)
2025 guideline · checked on 10 November 2026.
Frequently asked questions
Does the medicine replace healthy behaviours?
No. WHO places these therapies within comprehensive care including nutrition, activity and professional support. Habits do not replace an indicated treatment, and treatment does not replace comprehensive care.
Will I regain weight after stopping?
Regain is possible. A STEP 1 subgroup regained on average approximately two thirds of prior weight loss within a year after treatment and lifestyle intervention withdrawal. This does not predict your individual result.
Does the online plan replace medical follow-up?
No. Longevity Online organises wellbeing habits. Medicines, adverse effects and therapeutic nutrition need separate healthcare follow-up.
Original sources
Source publication date or date regulatory information was checked.
- WHO · Obesity and overweight(Opens in a new tab)
2026-10-07
https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
- WHO · Global guideline on GLP-1 medicines and obesity(Opens in a new tab)
2025-12-01
https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity
- Wilding et al. · STEP 1 extension · Diabetes, Obesity and Metabolism(Opens in a new tab)
2022-05-19
https://pubmed.ncbi.nlm.nih.gov/35441470/